BIO-RAD LABORATORIES, INC. BIO Income Statement

Bio-rad laboratories, inc. (BIO)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Net sales
2,329	2,311	2,304	2,288	2,291	2,289	2,293	2,282	2,211	2,160	2,110	2,084	2,097	2,068	2,067	2,028	2,017	2,019	2,047	2,107	2,138	2,175	2,179	2,153	2,142	2,132	2,103	2,097	2,082	2,069	2,045	2,063	2,074	2,073	2,057	2,011	1,958	1,927	1,854	1,810	0	0	0
Cost of goods sold
1,066	1,054	1,044	1,049	1,059	1,066	1,058	1,034	991	972	953	947	952	929	935	912	902	897	916	952	965	996	995	974	960	954	933	937	934	914	893	888	894	894	890	875	846	835	802	782	0	0	0
Gross profit
1,262	1,256	1,259	1,238	1,232	1,223	1,235	1,248	1,219	1,187	1,157	1,137	1,144	1,138	1,132	1,116	1,115	1,121	1,130	1,155	1,173	1,178	1,183	1,179	1,182	1,178	1,170	1,160	1,147	1,155	1,152	1,174	1,179	1,178	1,166	1,136	1,111	1,091	1,052	1,027	0	0	0
Selling, general and administrative expense
810	824	824	824	833	834	822	819	821	806	823	826	819	814	789	775	763	761	776	791	794	808	815	814	814	798	771	729	696	681	668	685	699	695	698	669	649	635	612	607	0	0	0
Research and Development Expense
204	202	198	200	197	199	222	234	250	250	231	219	206	205	204	197	194	192	196	205	214	220	216	217	213	210	211	206	206	209	194	191	187	177	181	179	174	172	166	166	0	0	0
Impairment losses on goodwill and long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Segment profit (loss)
247	229	-56	-77	-90	-103	179	182	136	119	42	31	56	55	135	140	158	166	157	158	163	149	151	147	154	169	187	224	244	264	289	297	292	305	287	287	287	284	273	254	0	0	0
Interest expense
23	23	23	24	24	23	23	23	23	23	23	23	23	23	22	23	22	21	20	22	23	22	24	48	54	61	67	48	48	51	49	49	49	53	61	63	66	63	57	53	0	0	0
Foreign exchange (gains) losses, net
-1	-2	-4	-4	-2	-2	-3	-6	-8	-9	-8	-6	-5	-4	-4	-5	-7	-10	-12	-13	-10	-9	-8	-8	-9	-8	-7	-4	-5	-5	-5	-11	-12	-13	-12	-8	-6	-3	-2	2	0	0	0
Marketable Securities, Unrealized Gain (Loss)
1,799	2,030	570	1,279	849	606	1,420	1,102	815	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Nonoperating Income (Expense)
10	26	34	32	44	36	26	25	20	10	13	13	13	13	15	15	11	11	12	12	13	13	11	11	12	12	17	18	16	21	16	15	13	7	7	7	5	3	2	-4	0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
2,032	2,261	520	1,205	776	512	1,599	1,280	941	97	23	15	41	41	123	126	139	145	137	134	143	131	130	102	102	112	130	190	207	229	251	251	243	245	219	221	218	220	214	205	0	0	0
(Provision) benefit for income taxes
453	502	143	300	202	147	323	250	174	-24	6	2	15	15	29	33	35	36	34	37	43	42	50	41	38	34	39	49	53	64	69	66	66	67	32	35	34	33	56	33	0	0	0
Net income including noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	79	61	64	77	91	140	154	165	182	185	176	178	186	185	184	186	158	152	0	0	0
Net loss (income) attributable to noncontrolling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-0	-0	0	0	0	0	-0	-0	-0	0	0	1	2	0	0	0	0
Net Income (Loss) Attributable to Parent
1,579	1,758	376	904	574	365	1,276	1,029	766	122	16	13	26	26	94	93	103	109	102	96	99	88	79	61	64	77	91	140	154	165	182	185	176	179	186	185	183	185	156	149	0	0	0
Basic earnings per share:
Net income per share basic attributable to Bio-Rad
22.97	18.50	-8.68	20.08	29.03	-27.81	9.02	8.99	22.05	2.79	0.74	0.17	0.42	-0.78	0.63	0.61	0.42	1.56	0.59	0.98	0.61	1.35	0.40	1.10	0.23	1.05	-0.25	1.21	0.71	1.53	1.51	1.71	1.10	2.15	1.63	1.43	1.18	2.44	1.62	1.37	1.27	1.40	1.39
Weighted Average Number of Shares Outstanding, Basic
29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	29	28	28	28	28	28	28	28	28	28	28	28	28	28	28	27	27	27	27	27	27	27
Diluted earnings per share:
Net income per share diluted attributable to Bio-Rad
22.72	18.35	-8.68	19.86	28.74	-27.43	8.89	8.87	21.77	2.76	0.73	0.17	0.41	-0.77	0.62	0.61	0.42	1.54	0.59	0.97	0.61	1.34	0.39	1.09	0.23	1.04	-0.25	1.20	0.70	1.51	1.49	1.69	1.09	2.11	1.61	1.41	1.16	2.41	1.59	1.35	1.24	1.38	1.37
Weighted Average Number of Shares Outstanding, Diluted
30	30	29	30	30	30	30	30	30	30	30	30	29	29	29	29	29	29	29	29	29	29	29	29	29	29	28	28	28	28	28	28	28	28	28	28	28	28	28	28	28	27	27